Table 2.
Histopathological data for patients with, respectively, giant (G-HCC) and small (S-HCC) hepatocellular carcinoma
| S-HCC n (%) | G-HCC n (%) | P-value | |
|---|---|---|---|
| Patients, n | 63 | 23 | |
| Gross vascular invasion | |||
| (n = 62) | (n = 23) | ||
| Yes | 4 (6.5%) | 0 | 0.570 |
| No | 58 (93.5%) | 23 (100%) | |
| Microvascular invasion | |||
| (n = 62) | (n = 23) | ||
| Yes | 13 (21.0%) | 11 (47.8%) | 0.028 |
| No | 49 (79.0%) | 12 (52.2%) | |
| Perineural invasion | |||
| (n = 62) | (n = 23) | ||
| Yes | 2 (3.2%) | 0 | 1.000 |
| No | 60 (96.8%) | 23 (100%) | |
| Lymphoinvasion | |||
| (n = 62) | (n = 23) | ||
| Yes | 11 (17.7%) | 9 (39.1%) | 0.048 |
| No | 51 (82.3%) | 14 (60.9%) | |
| Presence of tumour capsule | |||
| (n = 63) | (n = 23) | ||
| Yes | 37 (58.7%) | 18 (78.3%) | 0.129 |
| No | 26 (41.3%) | 5 (21.7%) | |
| Tumour capsule invasion | |||
| (n = 36) | (n = 18) | ||
| Yes | 11 (30.6%) | 3 (16.7%) | 0.339 |
| No | 25 (69.4%) | 15 (83.3%) | |
| Presence of satellite lesions | |||
| (n = 62) | (n = 23) | ||
| Yes | 12 (19.4%) | 5 (21.7%) | 0.770 |
| No | 50 (80.6%) | 18 (78.3%) | |
| Presence of tumour rupture | |||
| (n = 61) | (n = 23) | ||
| Yes | 6 (9.8%) | 2 (8.7%) | 1.00 |
| No | 55 (90.2%) | 21 (91.3%) | |
| Margins involved | |||
| (n = 61) | (n = 23) | ||
| Yes | 1 (1.6%) | 3 (13.0%) | 0.061 |
| No | 60 (98.4%) | 20 (87.0%) | |
| Presence of liver cirrhosis | |||
| (n = 63) | (n = 23) | ||
| Yes | 32 (50.8%) | 3 (13.0%) | 0.002 |
| No | 31 (49.2%) | 20 (87.0%) | |
P-values in bold indicate differences of statistical significance at P < 0.05.